Immuron Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immuron Limited with three other
pharmaceutical manufacturers in Australasia:
sales of 3.33 million Australian Dollars [US$2.64 million]
Anatara Lifesciences Ltd
(3.15 million Australian Dollars [US$2.50 million]
(3.16 million Australian Dollars [US$2.50 million]
Sales increased substantially in 2017:
During the year ended June of 2017, sales at
Immuron Limited were A$2.98 million (US$2.36 million).
increase of 157.9%
versus 2016, when the company's sales were A$1.16 million.
This was the fourth straight year of sales growth at Immuron Limited.